好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2018 Annual Meeting | C145 - Severe TBI: From ICU to Rehabilitation

Wednesday 04/25/18
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Susanne Muehlschlegel, MD, MPH, FAAN
Aging, Dementia, and Behavioral Neurology, Neuro Trauma, Critical Care, and Sports Neurology
Participants should be familiar with the variety of pathophysiologic mechanisms associated with TBI and how to prevent or minimize secondary brain injury with up-to-date acute management recommendations emphasizing relevant guidelines; and be comfortable using clinical information and imaging techniques to aid in prognostication after severe TBI.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Neurohospitalist
Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist
Case-based, Didactic, Audience Participation
Event Timeline
01:00 PM - 01:30 PM Speaker Severe TBI in the ICU: Management and Prognosis
Susanne Muehlschlegel, MD, MPH, FAAN
01:30 PM - 02:00 PM Speaker Imaging in Severe TBI
Brian Edlow, MD
02:00 PM - 02:30 PM Speaker Pharmacological and Rehabilitative Approaches to Neurological Sequelae of TBI
David L. Brody, MD, PhD
02:30 PM - 03:00 PM Q&A Questions and Answers
Faculty Disclosures
Susanne Muehlschlegel, MD, MPH, FAAN Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acasti Pharma Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with 好色先生. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Brian Edlow, MD Dr. Edlow has received research support from NIH.
David L. Brody, MD, PhD Dr. Brody has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Family Mutual Insurance Company. Dr. Brody has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Missouri State Public Defender's Office. Dr. Brody has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kaigene, Inc. Dr. Brody has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cirrito Holdings, LLC. Dr. Brody has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Advise, Connect, Inspire LLC. Dr. Brody has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Algernon Pharmaceuticals. Dr. Brody has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Advances. Dr. Brody has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Luna Innovations. Dr. Brody has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mary Ann Liebert, Inc. The institution of Dr. Brody has received research support from US Department of Defense. Dr. Brody has received intellectual property interests from a discovery or technology relating to health care. Dr. Brody has received publishing royalties from a publication relating to health care. Dr. Brody has a non-compensated relationship as a Board of Scientific Councilors with NINDS that is relevant to AAN interests or activities. Dr. Brody has a non-compensated relationship as a Ad hoc member and subcommittee on Health Disparities Training- Lead with NINDS Advisory Council that is relevant to AAN interests or activities. Dr. Brody has a non-compensated relationship as a Clinical Practice Guidelines Working Group: member with NASEM TBI Action Collaborative that is relevant to AAN interests or activities.